ViroMed Co., Ltd. is a leading biotechnology company with a mission to discover and develop innovative biopharmaceuticals for human diseases. ViroMed’s numerous achievements since its inception demonstrate that it is one of the most scientifically advanced R&D companies in today’s global biopharmaceutical industry. The company has differentiated itself from competitors with its core technology and seasoned management.
ViroMed is headquartered in Seoul, Korea with US presence in Atlanta. The company has assembled a diverse pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with multiple clinical studies ongoing in the US, Korea, and China. ViroMed is publicly ViroMed is publicly listed on KOSDAQ (084990).
Company Details
- Employees
- 9
- Address
- 1, Gwanak Gu, Gwanak Ro, 5th Fl. 203,snu,korea, Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- viromed.co.kr
- HQ
- Seoul, Seoul
Viromed Co., Ltd. Questions
Viromed Co., Ltd.'s website is viromed.co.kr
Viromed Co., Ltd.'s LinkedIn profile is https://kr.linkedin.com/company/viromedhr
Viromed Co., Ltd. has
9 employees.
View email and phone details for 9
employees at Viromed Co., Ltd..
Viromed Co., Ltd.'s industry is
Pharmaceutical Manufacturing
Viromed Co., Ltd.'s top competitors are
Geneuin-Tech,
Atheon Bio,
Birdrock Laboratories,
Viromed Lab,
Chemlex,
Viromed Medical Ag,
Genenuintech,
Decodecell,
Mobius Scientific,
Ngenebioai, Inc. (Formerly Bertis Bioscience).
Viromed Co., Ltd.'s categories are Pharmaceutical Manufacturing
